Anti-ACSL4 Polyclonal Antibody: A Powerful Tool for Studying Lipid Metabolism and Cancer Research
The Anti-ACSL4 Polyclonal Antibody is a highly specific and sensitive tool for studying lipid metabolism and cancer research. This antibody targets the ACSL4 protein, which plays a crucial role in the biosynthesis of fatty acids and their incorporation into cellular membranes. It is an essential enzyme for maintaining lipid homeostasis and has been implicated in various diseases, including cancer.
Biological Function:
The ACSL4 protein belongs to the long-chain acyl-CoA synthetase (ACSL) family, which catalyzes the formation of fatty acyl-CoA from fatty acids and coenzyme A. The ACSL4 enzyme is primarily found in the endoplasmic reticulum (ER) and is responsible for activating long-chain fatty acids for various cellular processes, such as lipid synthesis, energy production, and membrane formation. It is also involved in the regulation of lipid droplet formation and lipid signaling pathways.
Main Applications:
The Anti-ACSL4 Polyclonal Antibody is widely used in both basic and clinical research. It is a valuable tool for investigating the role of ACSL4 in lipid metabolism and its potential implications in various diseases, particularly cancer. This antibody has been extensively used in studies on breast cancer, prostate cancer, and melanoma, where ACSL4 overexpression has been observed. It has also been shown to play a role in drug resistance and metastasis, making it a potential therapeutic target for cancer treatment.
Experimental Use Cases:
The Anti-ACSL4 Polyclonal Antibody has been used in a variety of experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence. It has been validated for use in human, mouse, and rat samples, ensuring its versatility for different research models. This antibody has been shown to have high specificity and sensitivity, allowing for accurate detection of ACSL4 expression levels in various tissues and cell lines.
In addition to cancer research, the Anti-ACSL4 Polyclonal Antibody has also been used in studies on lipid metabolism disorders, such as non-alcoholic fatty liver disease (NAFLD) and obesity. Its ability to specifically target ACSL4 makes it a valuable tool for understanding the role of this enzyme in these conditions and potentially identifying new therapeutic strategies.
In conclusion, the Anti-ACSL4 Polyclonal Antibody is a powerful and versatile tool for studying lipid metabolism and cancer research. Its high specificity and sensitivity, along with its various applications and experimental use cases, make it an essential addition to any laboratory studying these areas. With this antibody, researchers can gain a deeper understanding of the role of ACSL4 in disease and potentially identify new targets for treatment.
There are no reviews yet.